ARCHIVES

In Brief: Minna to Leave NCI For Texas Southwestern; Alexander Is Special Populations Branch Chief

This article is from The Cancer Letter archive.

Vol. 17 No. 08 | February 22, 1991

Download PDF Visit The Full Archive

Related Articles

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Congress Ignores construction Fund Reprogramming

February 18, 1977

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004